Balance Sheet
Cash Flow Statement
Beginning Cash Balance
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $200.0 million.

  • Dr Reddys Laboratories' Depreciation & Amortization (CF) was N/A to $27.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $27.0 million, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2025, which is 12.36% up from last year.
  • Dr Reddys Laboratories' Depreciation & Amortization (CF) amounted to $200.0 million in FY2025, which was up 12.36% from $178.0 million recorded in FY2024.
  • Dr Reddys Laboratories' 5-year Depreciation & Amortization (CF) high stood at $200.0 million for FY2025, and its period low was $154.0 million during FY2023.
  • For the 3-year period, Dr Reddys Laboratories' Depreciation & Amortization (CF) averaged around $177.3 million, with its median value being $178.0 million (2024).
  • In the last 5 years, Dr Reddys Laboratories' Depreciation & Amortization (CF) fell by 10.86% in 2022 and then climbed by 15.58% in 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Depreciation & Amortization (CF) (Yearly) stood at $175.0 million in 2021, then fell by 10.86% to $156.0 million in 2022, then dropped by 1.28% to $154.0 million in 2023, then rose by 15.58% to $178.0 million in 2024, then grew by 12.36% to $200.0 million in 2025.